MDCG guidance

MDCG 2020-3 Rev.1: Guidance on significant changes regarding the transitional provision under Article 120 of the MDR with regard to devices covered by certificates according to MDD or AIMDD

MDCG guidance · Notified bodies · May 2023

Key facts

Reference MDCG 2020-3 Rev.1
Title Guidance on significant changes regarding the transitional provision under Article 120 of the MDR with regard to devices covered by certificates according to MDD or AIMDD
Topic Notified bodies
Published May 2023
Document health.ec.europa.eu

At a glance

  • Yes Full text searchable in Orca1
  • MDCG 2020-3 Rev.1 (May 2023), MDCG 2020-3 (March 2020) Revisions on file

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About MDCG guidance documents

The Medical Device Coordination Group (MDCG), made up of EU member-state experts, endorses guidance on applying the Medical Devices Regulation (EU) 2017/745 and the In Vitro Diagnostic Regulation (EU) 2017/746. Each page here covers one document and all of its revisions.

Source: European Commission, Medical Device Coordination Group (MDCG) endorsed documents and other guidance. © European Union, reused under Commission Decision 2011/833/EU

Browse all MDCG guidance documents